Effects of tobacco on cytokine expression from human endothelial cells

Oral Diseases

Volumn 19, Issue 7, 2013, Pages 660-665

  Allam, E ^a,b   Delacruz, K ^a   Ghoneima, A ^a   Sun, J ^a   Windsor, Lj ^a  

^a INDIANA UNIVERSITY SCHOOL OF DENTISTRY   (United States)

^b NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Cytokines; Endothelial cells; Tobacco

Indexed keywords

CIGARETTE SMOKE CONDENSATE; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH REGULATED ONCOGENE ALPHA; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; LYMPHOTOXIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; NICOTINE; ONCOPROTEIN; RANTES; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CCL2 PROTEIN, HUMAN; CXCL1 CHEMOKINE; CXCL1 PROTEIN, HUMAN; IL10 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; SMOKE;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; DOWN REGULATION; DRUG EXPOSURE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; UMBILICAL VEIN ENDOTHELIAL CELL; ANALYSIS; CELL LINE; COMPARATIVE STUDY; CULTURE TECHNIQUE; DRUG EFFECTS; ENDOTHELIUM CELL; IMMUNOLOGY; SMOKE; TOBACCO;

CELL CULTURE TECHNIQUES; CELL LINE; CELL PROLIFERATION; CHEMOKINE CCL2; CHEMOKINE CXCL1; CYTOKINES; DOWN-REGULATION; ENDOTHELIAL CELLS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; NICOTINE; SMOKE; TOBACCO;

EID: 84882690573     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/odi.12050     Document Type: Article

References (37)

1. Al-Shibani N, Labban N, Allam E, Windsor LJ (2010). Tobacco: a risk factor for periodontal disease. In: Yamamoto Sho L, ed. Periodontal disease: symptoms, treatment, and prevention. Nova Science Publishers Inc.: Hauppauge, NY, pp. 128.
2. Armitage GC (2000). Periodontal infectious and cardiovascular diseases: how strong is the association? Oral Dis 6: 335-350.
3. Atilla G, Emingil G, Kose T, Berdeli A (2006). TGF-β1 gene polymorphisms in periodontal diseases. Clin Biochem 39: 929-934.
4. Barbour SE, Nakashima K, Zhang JB et al (1997). Tobacco and smoking: environmental factors that modify the host response (immune system) and have an impact on periodontal health. Crit Rev Oral Biol Med 8: 437-460.
5. Brikadel-Hansen H (1993). Role of matrix metalloproteinases in human periodontal diseases. J Periodontol 64: 474-484.
6. Burg J, Krump-Konvalinkova V, Bittinger F, Kirkpatrick CJ (2002). GM-CSF expression by human lung microvascular endothelial cells: in vitro and in vivo findings. Am J Physiol Lung Cell Mol Physiol 283: L460-L467.
7. Clarke NG, Shephard BC, Hirsch RS (1981). The effect of intraarterial epinephrine and nicotine on gingival circulation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 52: 577-582.
8. Claudino M, Trombone AP, Cardoso CR et al (2008). he broad effects of the functional IL-10 promoter- 592 polymorphism: modulation of IL-10, TIMP-3, and OPG expression and their association with periodontal disease outcome. J Leukoc Biol 84: 1565-1573.
9. Elkind MS, Cole JW (2006). Do common infections cause stroke? Semin Neurol 26: 88-99.
10. Garlet GP (2010). Destructive and protective roles of cytokines in periodontitis: a re-appraisal from host defense and tissue destruction viewpoints. J Dent Res 89: 1349-1363.
11. Garlet GP, Martins W Jr, Fonseca BA, Ferreira BR, Silva JS (2004). Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differentially regulated by the cytokine profile in human periodontal disease. J Clin Periodontol 31: 671-679.
12. Garlet GP, Cardoso CR, Campanelli AP, Martins W Jr, Silva JS (2006). Expression of suppressors of cytokine signaling in diseased periodontal tissues: a stop signal for disease progression? J Periodontal Res 41: 580-584.
13. Genco R, Offenbacher S, Beck J (2002). Periodontal disease and cardiovascular disease. Epidemiology and possible mechanisms. JADA 133: 14S-22S.
14. Gritz ER, Dresler C, Sarna L (2005). Smoking, The Missing Drug Interaction in Clinical Trials: ignoring the Obvious. Cancer Epidemiol Biomarkers Prev 14: 2287-2293.
15. Grossi SG, Zambon J, Machtei EE et al (1997). Effects of smoking and smoking cessation on healing after mechanical periodontal therapy. JADA 128: 599-607.
16. Hansson GK (2005). Inflammatory, atherosclerosis and coronary artery disease. N Engl J Med 352: 1685-1695.
17. Heasman L, Stacey F, Preshaw PM, McCracken GI, Hepburn S, Heasman PA (2006). The effect of smoking on periodontal treatment response: a review of clinical evidence. J Clin Periodontol 33: 241-253.
18. Hujoel PP, Drangsholt MT, Spiekerman C, DeRouen TA (2001). Periodontal disease and risk of coronary heart disease. JAMA 285: 40-41.
19. Hyman JJ, Winn DM, Reid BC (2002). The role of cigarette smoking in the association between periodontal disease and coronary heart disease. J Periodontol 73: 988-994.
20. Johnson GK (2004). Cigarette Smoking and the Periodontal Patient. J Periodontol 75: 196-209.
21. Johnson GK, Slach NA (2001). Impact of tobacco use on periodontal status. J Dent Educ 65: 313-321.
22. Johnson JD, Houchens DP, Kluwe WM, Craig DK, Fisher GL (1990). Effects of mainstream and environmental tobacco smoke on the immune system in animals and humans. A review. Crit Rev Toxicol 20: 369-395.
23. Kenney EB, Kraal JH, Saxe SR, Jones J (1997). The effect of cigarette smoke on human oral polymorphonuclear leukocytes. J Periodontal Res 12: 227-234.
24. Kinane DF (2001). Causation and pathogenesis of periodontal disease. Periodontol 2000 25: 8-20.
25. Kinane DF, Lowe GD (2000). How periodontal disease may contribute to cardiovascular disease. Periodontol 2000 23: 121-126.
26. Loos BG, Craandijk J, Hoek FJ, Dillen P, Velden U (2000). Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol 71: 1528-1534.
27. Mendall MA, Patel P, Asante M et al (1997). Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart 78: 273-277.
28. Meurman JH, Sanz M, Janket S (2004). Oral health, atherosclerosis, and cardiovascular disease. Crit Rev Oral Biol Med 15: 403-413.
29. Musso T, Espinoza-Delgado I, Pulkki K, Gusella GL, Longo DL, Varesio L (1990). Transforming growth factor beta downregulates interleukin-1 (IL-1)-induced IL-6 production by human monocytes. Blood 76: 2466-2469.
30. Okada H, Murakami S (1998). Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med 9: 248-266.
31. Pittilo RM (2000). Cigarette smoking, endothelial injury and cardiovascular disease. Int J Exp path 81: 219-230.
32. Raulin LA, McPherson JC, McQuade MJ, Hanson BS (1988). The effect of nicotine on the attachment of human fibroblasts to glass and human root surfaces in vitro. J Periodontol 59: 318-325.
33. Romani F, Lanzone A, Tropea A, Tiberi F, Catino S, Apa R (2011). Nicotine and cotinine affect the release of vasoactive factors by trophoblast cells and human umbilical vein endothelial cells. Placenta 32: 153-160.
34. Scannapieco FA, Bush RB, Paju S (2003). association between periodontal disease and risk for atherosclerosis, cardiovascular disease, and stroke. A systematic review. Ann Periodontol 8: 38-53.
35. Sharentuya N, Tomimatsu T, Mimura K et al (2010). Nicotine suppresses interlukin-6 production from vascular endothelial cells: a possible therapeutic role of nicotine for preeclampsia. Reprod Sci 17: 556-563.
36. Yoshimura A, Mori H, Ohishi M, Aki D, Hanada T (2003). Negative regulation of cytokine signaling influences inflammation. Curr Opin Immunol 15: 704-708.
37. Yoshimura A, Naka T, Kubo M (2007). SOCS proteins, cytokine signaling and immune regulation. Nat Rev Immunol 7: 454-465.